Idexx Laboratories | IDXX - Selling And Administration Expenses

Stock Price
632.56
Daily Change
-7.04 -1.10%
Monthly
-7.28%
Yearly
36.03%
Q1 Forecast
649.81

Idexx Laboratories reported $275.68M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.13B 125M Dec/2025
Align Technology USD 417.8M 30.89M Sep/2025
Dentsply International USD 355M 21M Sep/2025
Dexcom USD 331.4M 3.4M Sep/2025
Edwards Lifesciences USD 514.6M 12.6M Sep/2025
Fujifilm JPY 212.9B 16.26B Sep/2025
Globus Medical USD 313.6M 9.98M Sep/2025
Henry Schein USD 760M 17M Sep/2025
Hologic USD 2.5B 2.24B Dec/2025
Idexx Laboratories USD 275.68M 10.58M Dec/2025
Insulet USD 315.2M 61.9M Sep/2025
Integra LifeSciences USD 169.05M 10.84M Sep/2025
Intuitive Surgical USD 687.1M 113.8M Dec/2025
Masimo USD 116.4M 20.5M Sep/2025
Neogen USD 107.5M 1.56M Sep/2025
ResMed USD 278.4M 19.2M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Steris USD 349.7M 4.1M Sep/2025
Tandem Diabetes Care USD 94.52M 1.47M Sep/2025
Teleflex USD 281.76M 66.68M Sep/2025
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
Zoetis USD 579M 29M Sep/2025